Trump Signs Order to Reduce Regulatory Barriers to Domestic Pharmaceutical Manufacturing

May 5, 2025 4:52 PM EDT
(Updated - May 5, 2025 4:53 PM EDT)

White House: Trump Signs Order to Reduce Regulatory Barriers to Domestic Pharmaceutical Manufacturing

  • Trump order directs the FDA to reduce the amount of time it takes to approve domestic pharmaceutical manufacturing plants.
  • Trump order directs the FDA to increase fees for and inspections of foreign manufacturing plants.
  • Trump order directs FDA to improve enforcement of active pharmaceutical ingredient source reporting by foreign drug producers and consider publicly displaying a list of facilities that do not comply.
  • Trump order directs EPA to accelerate construction of facilities designed to manufacture prescription drugs, active pharmaceutical ingredients, and other necessary raw materials


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

FDA, Politics, Trader Talk

Related Entities

Maynard Um, Mark Zuckerberg, FDA, ARK